138 related articles for article (PubMed ID: 22403059)
1. Bilateral subdural hemorrhage as a serious adverse event of dasatinib in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Yhim HY; Kim HS; Lee NR; Song EK; Kwak JY; Yim CY
Int J Hematol; 2012 May; 95(5):585-7. PubMed ID: 22403059
[No Abstract] [Full Text] [Related]
2. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
3. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
Sonmez M; Cobanoglu U; Ovali E; Omay SB
J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
[No Abstract] [Full Text] [Related]
4. Rapid-onset pulmonary arterial hypertension in a patient with acute lymphoblastic leukemia treated with dasatinib.
Kim JC; Shin SH; Yi HG; Kim SH; Woo SI; Kim DH; Park KS; Kwan J
Herz; 2013 Dec; 38(8):931-3. PubMed ID: 23430094
[No Abstract] [Full Text] [Related]
5. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.
Mustafa Ali MK; Sabha MM; Al-Rabi KH
Platelets; 2015; 26(5):491-4. PubMed ID: 25025538
[TBL] [Abstract][Full Text] [Related]
6. Severe hemorrhagic colitis caused by dasatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shimokaze T; Mitsui T; Takeda H; Kawakami T; Arai T; Ito M; Iwaba A; Izumino H; Takahashi N; Kanno M; Sendo D; Hayasaka K
Pediatr Hematol Oncol; 2009 Sep; 26(6):448-53. PubMed ID: 19657995
[No Abstract] [Full Text] [Related]
7. Reversible cardiotoxicity with tyrosine kinase inhibitors.
Francis J; Ahluwalia MS; Wetzler M; Wang E; Paplham P; Smiley S; McCarthy PL; Cohen IL; Spangenthal E; Battiwalla M
Clin Adv Hematol Oncol; 2010 Feb; 8(2):128-32. PubMed ID: 20386534
[No Abstract] [Full Text] [Related]
8. Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia.
Ohta S; Najima Y; Imamura J
Br J Haematol; 2015 Jun; 169(5):612. PubMed ID: 25855138
[No Abstract] [Full Text] [Related]
9. Dasatinib dosing strategies in Philadelphia chromosome-positive leukemia.
Wong SF
J Oncol Pharm Pract; 2009 Mar; 15(1):17-27. PubMed ID: 18753186
[TBL] [Abstract][Full Text] [Related]
10. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
Czyz A; Lewandowski K; Kroll R; Komarnicki M
Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
[TBL] [Abstract][Full Text] [Related]
11. Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis.
Kobayashi Y; Sakamaki H; Fujisawa S; Ando K; Yamamoto K; Okada M; Ishizawa K; Nagai T; Miyawaki S; Motoji T; Usui N; Iida S; Taniwaki M; Uoshima N; Seriu T; Ohno R
Int J Hematol; 2011 Jun; 93(6):745-749. PubMed ID: 21594763
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment.
Chang H; Hung YS; Chou WC
Int J Infect Dis; 2014 Aug; 25():165-7. PubMed ID: 24932855
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonitis associated with dasatinib treatment for chronic myeloid leukemia or acute lymphoblastic leukemia: case series and a literature review.
Kim SA; Kwon BS; Chung JH; Lee JY; Bang SM; Lee JO
Ther Adv Respir Dis; 2022; 16():17534666221135322. PubMed ID: 36346055
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic post-transplant dasatinib administration in a pediatric patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Watanabe A; Chansu S; Ogawa A; Asami K; Imamura M
Pediatr Int; 2013 Jun; 55(3):e56-8. PubMed ID: 23782380
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation.
Ishida Y; Terasako K; Oshima K; Sakamoto K; Ashizawa M; Sato M; Kikuchi M; Kimura S; Nakasone H; Okuda S; Kako S; Yamazaki R; Nishida J; Kanda Y
Int J Hematol; 2010 Oct; 92(3):542-6. PubMed ID: 20824399
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Keam SJ
BioDrugs; 2008; 22(1):59-69. PubMed ID: 18215092
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of tyrosine kinase inhibitor dasatinib plus chemotherapy in the treatment of childhood Philadelphia chromosome-positive acute lymphoblastic leukemia].
Guo Y; Liu TF; Yang WY; Wang SC; Ruan M; Chen XJ; Zhang L; Liu F; Zou Y; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):634-7. PubMed ID: 26108329
[No Abstract] [Full Text] [Related]
18. New approved dasatinib regimen available for clinical use.
Snyder DS
Expert Rev Anticancer Ther; 2009 Mar; 9(3):285-92. PubMed ID: 19275507
[TBL] [Abstract][Full Text] [Related]
19. [Dasatinib-related pneumonia? An example of pharmacovigilance survey].
Audemard A; de la Gastine B; Chantepie S; Verger H; Gac AC; Bergot E; Reman O
Rev Mal Respir; 2015 Jan; 32(1):84-6. PubMed ID: 25618211
[No Abstract] [Full Text] [Related]
20. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
